“Risk Comes From Not Knowing What You Are Doing.”
- Warren Buffett
About The Principal
David Lazar is currently a private investor who specializes in "Turnaround Situations" distressed public companies. He is actively seeking high growth private companies who are looking to explore transitioning into the public markets.
David has been involved in the Capital Markets for nearly a decade. He has diverse knowledge of financial, legal and operations management; public company management, accounting, private placements, audit preparation, capital raising, due diligence reviews, and SEC regulations.
Other expertise include: capital restructuring, reverse merger, debt financing, SPAC, equity lines, and mergers and acquisitions. David has additional experience in assisting OTC listed companies prepare for a Nasdaq Uplisting.
David has been involved in the Capital Markets for nearly a decade. He has diverse knowledge of financial, legal and operations management; public company management, accounting, private placements, audit preparation, capital raising, due diligence reviews, and SEC regulations.
Other expertise include: capital restructuring, reverse merger, debt financing, SPAC, equity lines, and mergers and acquisitions. David has additional experience in assisting OTC listed companies prepare for a Nasdaq Uplisting.
Investment Philosophy
David's investment philosophy is looking for “diamonds in the rough". Companies which have long lost favor in the eyes of Wall Street and drastically need a comeback. He seeks to invest in companies for which we can actively work with management in order to restore much needed shareholder value.
In other investment scenarios, when management is already on the right track, he merely seeks to invest in order to join in for the ride. Although this investment strategy comes with substantial high risk, we believe that it can bear great reward. Through this meticulous Due Diligence process that is conducted on every potential investment, he feels that he can properly mitigate avoidable risk.
In other investment scenarios, when management is already on the right track, he merely seeks to invest in order to join in for the ride. Although this investment strategy comes with substantial high risk, we believe that it can bear great reward. Through this meticulous Due Diligence process that is conducted on every potential investment, he feels that he can properly mitigate avoidable risk.
As Warren Buffett once said, “fearful when others are greedy, and greedy when others are fearful.”
Recent Transactions
KALA Bio’s Bold Move: A New Dawn?
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Why Did KALA BIO Shares Jump Over 22% After Hours?
KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards
Black Titan (NASDAQ:BTTC) climbed nearly 300% on Thursday as it announced Wednesday the completion of its previously disclosed business combination with Titan pharmaceuticals
NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share
NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
David E. Lazar just filed a 13G for Matinas Biopharma (NYSE:MTNB) on August 15, 2025
FiEE, Inc. Acquires Advanced Tech Suite Expected to Supercharge IoT-AI Content & Audience Targeting Platform
FiEE, Inc. Closes Its First Day of Trading on NASDAQ
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
In The News/Blog
Jul 13, 2025
Crypto Treasury Firms Swarm Wall Street in SPAC, Merger Boom
Jul 22, 2024
Lionel Messi’s fashion royalties and shipping’s road to Nasdaq
Jun 23, 2024
Aeglea Biotherapeutics up 328% - call this what it is, a reverse takeover by Spyre
Aug 29, 2023
No Product, No Sales, No Prospects? Consider a Reverse Merger
Mar 22, 2023
Life Sciences Reverse Mergers Go Global: Is it the Path for Your Company?
Mar 02, 2023
Startups Opt For Microcap Mergers To Tap Public Markets
Dec 20, 2020
SPAC VS "Ordinary" Reverse Merger
Jun 22, 2020
